152 related articles for article (PubMed ID: 15320885)
41. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
[TBL] [Abstract][Full Text] [Related]
42. Mycobacteria-primed macrophages and dendritic cells induce an up-regulation of complement C5a anaphylatoxin receptor (CD88) in CD3+ murine T cells.
Connelly MA; Moulton RA; Smith AK; Lindsey DR; Sinha M; Wetsel RA; Jagannath C
J Leukoc Biol; 2007 Jan; 81(1):212-20. PubMed ID: 16997854
[TBL] [Abstract][Full Text] [Related]
43. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
44. Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus.
Mahadevan M; Liu Y; You C; Luo R; You H; Mehta JL; Hermonat PL
Cancer Immunol Immunother; 2007 Oct; 56(10):1615-24. PubMed ID: 17356843
[TBL] [Abstract][Full Text] [Related]
45. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
Li CD; Zhang WY; Yuan CL; Han LY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
[TBL] [Abstract][Full Text] [Related]
46. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
47. Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells.
Renneson J; Salio M; Mazouz N; Goldman M; Marchant A; Cerundolo V
Clin Exp Immunol; 2005 Mar; 139(3):468-75. PubMed ID: 15730392
[TBL] [Abstract][Full Text] [Related]
48. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
[TBL] [Abstract][Full Text] [Related]
49. [Protective immunity against Mycobacterium tuberculosis].
Kawamura I
Kekkaku; 2006 Nov; 81(11):687-91. PubMed ID: 17154048
[TBL] [Abstract][Full Text] [Related]
50. CD4+ T-cell activation by antigen-presenting cells infected with urease-deficient recombinant Mycobacterium bovis bacillus Calmette-Guérin.
Mukai T; Maeda Y; Tamura T; Miyamoto Y; Makino M
FEMS Immunol Med Microbiol; 2008 Jun; 53(1):96-106. PubMed ID: 18400013
[TBL] [Abstract][Full Text] [Related]
51. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production.
Gagliardi MC; Teloni R; Giannoni F; Pardini M; Sargentini V; Brunori L; Fattorini L; Nisini R
J Leukoc Biol; 2005 Jul; 78(1):106-13. PubMed ID: 15845642
[TBL] [Abstract][Full Text] [Related]
52. Infection of mouse macrophages with viable Mycobacterium leprae does not induce apoptosis.
Lahiri R; Randhawa B; Krahenbuhl JL
J Infect Dis; 2010 Jun; 201(11):1736-42. PubMed ID: 20402595
[TBL] [Abstract][Full Text] [Related]
53. Killing of Brucella antigen-sensitized macrophages by T lymphocytes in bovine brucellosis.
Wyckoff JH; Potts RD
Vet Immunol Immunopathol; 2007 Dec; 120(3-4):148-59. PubMed ID: 17904229
[TBL] [Abstract][Full Text] [Related]
54. Parasitism of antigen presenting cells in hyperbacillary leprosy.
Poulter LW; Collings LA; Tung KS; Waters MF
Clin Exp Immunol; 1984 Mar; 55(3):611-7. PubMed ID: 6368061
[TBL] [Abstract][Full Text] [Related]
55. IFN-gamma, IL-6 and IL-4 modulate M. leprae- or PPD-specific cytotoxic T cells in leprosy patients.
Fink S; de la Barrera S; Minnucci F; Valdez R; Baliña LM; Sasiain MC
Scand J Immunol; 1993 Dec; 38(6):551-8. PubMed ID: 8256114
[TBL] [Abstract][Full Text] [Related]
56. Identification of an Immunomodulating Agent from Mycobacterium leprae.
Maeda Y; Mukai T; Spencer J; Makino M
Infect Immun; 2005 May; 73(5):2744-50. PubMed ID: 15845477
[TBL] [Abstract][Full Text] [Related]
57. Phagocytic and bactericidal activities of macrophages from Mycobacterium leprae-infected normal and immunosuppressed mice.
Vaishnavi C; Kumar B; Ganguly NK; Kaur S
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):233-7. PubMed ID: 3894539
[TBL] [Abstract][Full Text] [Related]
58. Lysis of autologous macrophages pulsed with hsp10 from Mycobacterium leprae is associated to the absence of bacilli in leprosy.
de la Barrera S; Fink S; Finiasz M; Alemán M; Helena Fariña M; Pizzariello G; del Carmen Sasiain M
Immunol Lett; 2001 Feb; 76(1):55-62. PubMed ID: 11222914
[TBL] [Abstract][Full Text] [Related]
59. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
Spierings E; De Boer T; Zulianello L; Ottenhoff TH
Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
[TBL] [Abstract][Full Text] [Related]
60. Radiolabelled M. leprae resident in human macrophage cultures as an in vitro indicator of effective immunity in human leprosy.
Prasad HK; Singh R; Nath I
Clin Exp Immunol; 1982 Sep; 49(3):517-22. PubMed ID: 6756718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]